Cutler Group LP Seres Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	BUY	$2.33 - $5.07 $9,320 - $20,280	4,000 Added 160.0%	6,500 $0
Q2 2023 Jul 18, 2023	BUY	$4.67 - $6.55 $11,675 - $16,375	2,500 New	2,500 $2,000
Q1 2022 Apr 14, 2022	SELL	$6.3 - $8.84 $6,930 - $9,724	-1,100 Reduced 91.67%	100 $0
Q4 2021 Jan 18, 2022	SELL	$6.02 - $11.43 $5,418 - $10,287	-900 Reduced 42.86%	1,200 $0
Q3 2021 Oct 26, 2021	SELL	$5.46 - $22.6 $1,638 - $6,780	-300 Reduced 12.5%	2,100 $0
Q1 2021 Apr 26, 2021	SELL	$17.66 - $28.92 $8,830 - $14,460	-500 Reduced 17.24%	2,400 $1,000
Q4 2020 Jan 21, 2021	SELL	$23.25 - $37.73 $139,500 - $226,379	-6,000 Reduced 67.42%	2,900 $15,000
Q3 2020 Oct 27, 2020	BUY	$3.74 - $28.74 $28,798 - $221,298	7,700 Added 641.67%	8,900 $28,000
Q3 2017 Oct 17, 2017	BUY	$12.81 - $16.85 $15,372 - $20,220	1,200	1,200 $2,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.